Lynx patents fluid microbead DNA arrays:
This article was originally published in Clinica
The US Patent Office has granted Lynx Therapeutics two patents relating to "fluid microarrays" for analysing cDNA libraries. The patents support the Hayward, California-based company's programme to develop a technology in which microbeads carrying multiple copies of DNA fragments could be an alternative to chip or surface DNA microarrays.
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.